Patent details
EP1871769 Title: CRYSTALLINE FORMS OF THE COMPOUND 4-(6-CHLORO-2,3-METHYLENEDIOXYANILINO)-7-[2-(4-METHYLPIPERAZIN-1-YL)ETHOXY]-5-TETRAHYDROPYRAN-4-YLOXYQUINAZOLINE.
Basic Information
- Publication number:
- EP1871769
- PCT Application Number:
- GB2005004807
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP058181272
- PCT Publication Number:
- WO2006064217
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- CRYSTALLINE FORMS OF THE COMPOUND 4-(6-CHLORO-2,3-METHYLENEDIOXYANILINO)-7-[2-(4-METHYLPIPERAZIN-1-YL)ETHOXY]-5-TETRAHYDROPYRAN-4-YLOXYQUINAZOLINE.
- French Title of Invention:
- DES FORMES CRISTALLINES DU COMPOSÉ 4-(6-CHLORO-2,3-METHYLENEDIOXYANILINO)-7-[2-(4-METHYLPIPERAZIN-1-YL) ETHOXY]-5-TETRAHYDROPYRAN-4-YLOXYQUINAZOLINE.
- German Title of Invention:
- KRISTALLINE FORMEN DER VERBINDUNG 4-(6-CHLOR-2,3-METHYLENDIOXYANILINO)-7-[2-(4-METHYLPIPERAZIN-1-YL)ETHOXY]-5-TETRAHYDROPYRAN-4-YLOXYCHINAZOLIN.
- SPC Number:
Dates
- Filing date:
- 14/12/2005
- Grant date:
- 22/02/2017
- EP Publication Date:
- 02/01/2008
- PCT Publication Date:
- 22/06/2006
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 22/02/2017
- EP B1 Publication Date:
- 22/02/2017
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 14/12/2017
- Expiration date:
- 14/12/2025
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 22/02/2017
- Name:
- AstraZeneca AB
- Address:
- Forskargatan 18, 151 85 Södertälje, Sweden (SE)
Inventor
1
- Name:
- FORD, James Gair AstraZeneca
- Address:
- United Kingdom (GB)
2
- Name:
- POINTON, Simon Mark AstraZeneca
- Address:
- United Kingdom (GB)
3
- Name:
- POWELL, Lyn AstraZeneca
- Address:
- United Kingdom (GB)
4
- Name:
- WITHNALL, Jane AstraZeneca R & D Charnwood
- Address:
- United Kingdom (GB)
5
- Name:
- PURDIE, Mark AstraZeneca R & D Charnwood
- Address:
- United Kingdom (GB)
6
- Name:
- O'KEARNEY-MCMULLAN, Anne AstraZeneca
- Address:
- United Kingdom (GB)
7
- Name:
- O'KEEFE, Philip AstraZeneca R & D Charnwood
- Address:
- United Kingdom (GB)
8
- Name:
- MCCABE, James Francis AstraZeneca
- Address:
- United Kingdom (GB)
Priority
- Priority Number:
- 0427697
- Priority Date:
- 17/12/2004
- Priority Country:
- United Kingdom (GB)
Classification
- IPC classification:
- A61K 31/517; C07D 405/12;
Publication
European Patent Bulletin
- Issue number:
- 201708
- Publication date:
- 22/02/2017
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|---|---|
| 30/04/2018 | Outgoing Correspondence | 1 |